Mobile Lads Corp. (MOBO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -2.26 Million USD | -1701.53% |
| 2021 | 141.32 Thousand USD | 114.25% |
| 2020 | -991.58 Thousand USD | 3.26% |
| 2019 | -1.02 Million USD | 0.0% |
| 2016 | -3.63 Million USD | -1159.33% |
| 2015 | -288.87 Thousand USD | -1079.09% |
| 2014 | -24.5 Thousand USD | -231.08% |
| 2013 | -7400.00 USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | -112.72 Thousand USD | 15.82% |
| 2023 Q2 | -110.13 Thousand USD | 2.3% |
| 2022 Q1 | -1.94 Million USD | 0.0% |
| 2022 FY | -2.26 Million USD | -1701.53% |
| 2022 Q4 | -133.91 Thousand USD | -17.81% |
| 2022 Q3 | -113.67 Thousand USD | -2681.99% |
| 2022 Q2 | -4086.00 USD | 99.79% |
| 2021 FY | 141.32 Thousand USD | 114.25% |
| 2020 FY | -991.58 Thousand USD | 3.26% |
| 2019 FY | -1.02 Million USD | 0.0% |
| 2017 Q1 | -733.68 Thousand USD | -33.63% |
| 2016 Q4 | -549.06 Thousand USD | 75.16% |
| 2016 Q2 | -836 Thousand USD | -1858.41% |
| 2016 Q3 | -2.21 Million USD | -164.37% |
| 2016 Q1 | -42.68 Thousand USD | -17.54% |
| 2016 FY | -3.63 Million USD | -1159.33% |
| 2015 FY | -288.87 Thousand USD | -1079.09% |
| 2015 Q4 | -36.31 Thousand USD | 26.79% |
| 2015 Q3 | -49.6 Thousand USD | 51.82% |
| 2015 Q2 | -102.95 Thousand USD | -691.11% |
| 2015 Q1 | -13.01 Thousand USD | -674.64% |
| 2014 FY | -24.5 Thousand USD | -231.08% |
| 2014 Q1 | -2571.00 USD | 0.0% |
| 2014 Q2 | -1979.00 USD | 23.03% |
| 2014 Q4 | -1680.00 USD | 90.8% |
| 2014 Q3 | -18.25 Thousand USD | -822.39% |
| 2013 FY | -7400.00 USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -69.48% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 67.588% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 104.272% |
| Nascent Biotech, Inc. | -2.08 Million USD | -8.412% |
| Rebus Holdings, Inc. | -1.02 Million USD | -121.891% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 103.475% |
| Qrons Inc. | -789.34 Thousand USD | -186.73% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -257.885% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 96.384% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -444.743% |
| Skye Bioscience, Inc. | -37.64 Million USD | 93.988% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 96.981% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 65.583% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -727.826% |
| SQZ Biotechnologies Company | -79.46 Million USD | 97.152% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | 21.75% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -24.321% |
| Mesoblast Limited | -87.95 Million USD | 97.427% |
| Marizyme, Inc. | -65.34 Million USD | 96.536% |
| Genus plc | 7.9 Million USD | 128.649% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 79.22% |
| Pharming Group N.V. | -10.54 Million USD | 78.543% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -4.308% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | 38.999% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 74.409% |
| ContraFect Corporation | -65.15 Million USD | 96.526% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 53.679% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -31.019% |
| IMV Inc. | -36.48 Million USD | 93.797% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 71.918% |
| MultiCell Technologies, Inc. | -380.07 USD | -595393.462% |
| ONE Bio Corp. | 8.67 Million USD | 126.085% |
| Accustem Sciences Inc. | -3.74 Million USD | 39.588% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 95.622% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -78.615% |
| Q BioMed Inc. | -2.05 Million USD | -10.292% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | 39.371% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | 4.938% |
| Biomind Labs Inc. | -1.21 Million USD | -86.384% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 96.211% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | 27.032% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 71.362% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -16.111% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -15012.794% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 85.74% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 61.093% |
| GB Sciences, Inc. | -1.36 Million USD | -66.214% |
| Alpha Cognition Inc. | -13.77 Million USD | 83.567% |
| HST Global, Inc. | -146.21 Thousand USD | -1447.973% |
| CSL Limited | 2.64 Billion USD | 100.086% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -28.979% |
| Halberd Corporation | -79.67 Thousand USD | -2740.62% |
| Enzolytics Inc. | -2.17 Million USD | -3.972% |
| Agentix Corp. | -1.37 Million USD | -64.698% |
| Resverlogix Corp. | -3.61 Million USD | 37.305% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | 28.635% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 99.233% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 2409.482% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 132.685% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 43.033% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | 25.208% |
| AVAX Technologies, Inc. | -6.41 Million USD | 64.711% |
| Zenith Capital Corp. | -10.59 Million USD | 78.64% |
| Genscript Biotech Corporation | -95.47 Million USD | 97.629% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -9637.94% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 45.409% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -3644.654% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -12.876% |
| Kadimastem Ltd | -3.3 Million USD | 31.569% |
| Helix BioMedix, Inc. | -1.05 Million USD | -114.315% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 40.736% |
| BioStem Technologies, Inc. | -8.48 Million USD | 73.32% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -412.789% |
| LadRx Corporation | 400.44 Thousand USD | 665.197% |
| Cell Source, Inc. | -5.32 Million USD | 57.467% |
| Regen BioPharma, Inc. | 1.02 Million USD | 321.131% |
| Regen BioPharma, Inc. | 1.02 Million USD | 321.131% |
| NovAccess Global Inc. | -4.76 Million USD | 52.543% |
| Affymax, Inc. | -14.42 Million USD | 84.309% |
| Itoco Inc. | -1.86 Million USD | -21.097% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 49.054% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -35.608% |
| CytoDyn Inc. | -49.84 Million USD | 95.459% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -2763.73% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -892.119% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -140.385% |
| SYBLEU INC | -180.3 Thousand USD | -1155.264% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -40.339% |
| International Stem Cell Corporation | -131 Thousand USD | -1627.704% |
| Bioxytran, Inc. | -4.28 Million USD | 47.119% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -4070.276% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | 10.551% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 95.292% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -7.062% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -189.836% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | 28.558% |
| Neutra Corp. | -233.46 Thousand USD | -869.435% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 88.846% |
| PureTech Health plc | -65.69 Million USD | 96.555% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 89.357% |
| IXICO plc | -1.17 Million USD | -92.13% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 77.201% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 96.038% |
| CSL Limited | 2.64 Billion USD | 100.086% |
| Cellectis S.A. | -103.17 Million USD | 97.806% |